Drugs / 4-PBA
last change Oct 2003 re-read 3 minutes ago

4-PBA

Developed for
alpha 1-antitrypsin deficiency
Investigated by
Alpha-1 Foundation · Brantly, Mark L., M.D. · University of Florida

Trials 1

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00067756 Nov 2001 → Oct 2003 alpha 1-antitrypsin deficiency University of Florida Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 4-PBA ClinicalTrials.gov intervention name — accepted as the source's own label NCT00067756 ↗
Action Restore “4 Phenyl Butyrate Mediated Secretion Rescue” NCT00067756 ↗
Route Oral “4-PBA orally” NCT00067756 ↗